ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+14.1%
5Y CAGR+7.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+14.1%/yr
vs +8.6%/yr prior
5Y CAGR
+7.1%/yr
Recent acceleration
Acceleration
+5.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $548.89M | +12.4% |
| 2024 | $488.43M | +21.4% |
| 2023 | $402.47M | +9.0% |
| 2022 | $369.09M | -6.8% |
| 2021 | $396.03M | +1.9% |
| 2020 | $388.66M | +19.4% |
| 2019 | $325.64M | +22.5% |
| 2018 | $265.76M | +4.2% |
| 2017 | $255.06M | +36.8% |
| 2016 | $186.46M | - |